Decreased Perifoveal Sensitivity Detected by Microperimetry in Patients Using Hydroxychloroquine and without Visual Field and Fundoscopic Anomalies

Table 1

Clinical characteristics of the two groups of the analyzed sample.

	Control group	HCQ group
Age (years)	38.86 ± 12.56; (21 to 62)	40.86 ± 10.49; (31 to 62)
Sphere (D)	−0.20 ± 1.02; (−2.25 to 1.25)	−0.52 ± 1.61; (−4.25 to 0.75)
Cylinder (D)	−0.52 ± 0.83; (−2.50 to 0.00)	−0.52 ± 0.95; (−2.75 to 0.00)
Spherical equivalent (D)	−0.46 ± 0.94; (−2.25 to 1.25)	−0.78 ± 2.04; (−5.63 to 0.38)
CDVA (decimal scale)	1.00 ± 0.00; (1.00 to 1.00)	1.05 ± 0.16; (0.90 to 1.50)
Central thickness (m)	210.3 ± 42.3; (181 to 306)	209.7 ± 18.2; (176 to 232)
Average thickness (m)	272.0 ± 14.6; (258.9 to 301.3)	269.2 ± 14.7; (249.3 to 286.6)
Volume (mm^3)	7.69 ± 0.41; (7.32 to 8.52)	7.61 ± 0.41; (7.05 to 8.10)

CDVA: corrected distance visual acuity; D: diopters; m: micrometers.